283 related articles for article (PubMed ID: 21060077)
1. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077
[No Abstract] [Full Text] [Related]
2. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
[No Abstract] [Full Text] [Related]
3. [Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].
Würtz M; Grove EL
Ugeskr Laeger; 2013 Sep; 175(37):2094-8. PubMed ID: 24011204
[TBL] [Abstract][Full Text] [Related]
4. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
J Am Coll Cardiol; 2010 Dec; 56(24):2051-66. PubMed ID: 21126648
[No Abstract] [Full Text] [Related]
5. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ;
J Am Coll Cardiol; 2008 Oct; 52(18):1502-17. PubMed ID: 19017521
[No Abstract] [Full Text] [Related]
6. Risk of combining PPIs with thienopyridines: fact or fiction?
Sibbing D; Kastrati A
Lancet; 2009 Sep; 374(9694):952-954. PubMed ID: 19726077
[No Abstract] [Full Text] [Related]
7. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM;
Circulation; 2008 Oct; 118(18):1894-909. PubMed ID: 18836135
[No Abstract] [Full Text] [Related]
8. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ; ; ;
Am J Gastroenterol; 2008 Nov; 103(11):2890-907. PubMed ID: 18853965
[No Abstract] [Full Text] [Related]
9. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
10. ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.
; ; ; Holmes DR; Dehmer GJ; Kaul S; Leifer D; O'Gara PT; Stein CM
Circulation; 2010 Aug; 122(5):537-57. PubMed ID: 20585015
[No Abstract] [Full Text] [Related]
11. Response to antiplatelet treatment: from genes to outcome.
Giusti B; Abbate R
Lancet; 2010 Oct; 376(9749):1278-81. PubMed ID: 20801497
[No Abstract] [Full Text] [Related]
12. Prasugrel: an efficacy and safety review of a new antiplatelet therapy option.
Armani AM
Crit Pathw Cardiol; 2010 Dec; 9(4):199-202. PubMed ID: 21119337
[TBL] [Abstract][Full Text] [Related]
13. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220
[No Abstract] [Full Text] [Related]
14. Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
Moayyedi P; Sadowski DC
Can J Gastroenterol; 2009 Apr; 23(4):251-2. PubMed ID: 19373416
[No Abstract] [Full Text] [Related]
15. Proton pump inhibitors and clopidogrel.
Gaglia MA; Waksman R
Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
[TBL] [Abstract][Full Text] [Related]
16. NSAID-induced gastrointestinal and cardiovascular injury.
Ng SC; Chan FK
Curr Opin Gastroenterol; 2010 Nov; 26(6):611-7. PubMed ID: 20948372
[TBL] [Abstract][Full Text] [Related]
17. Desensitization to prasugrel: cardiology's increased need for allergy consultation.
Mutnick JL
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):124-5. PubMed ID: 22289733
[No Abstract] [Full Text] [Related]
18. Common drugs can harm elderly patients.
Voelker R
JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
[No Abstract] [Full Text] [Related]
19. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
Clemmensen P; Dridi NP; Holmvang L
Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
[TBL] [Abstract][Full Text] [Related]
20. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
